Why Cancer Patients Are at Higher Risk
Cancer patients and those who have recently undergone oncological treatment face heightened vulnerability to COVID-19 infection and its complications. This is due to immunosuppression from chemotherapy, radiotherapy or surgery, as well as the general debilitation associated with active malignancy.
Impact on Oncological Treatment
The COVID-19 pandemic required significant adaptations in oncological care: Surgical delays: Elective oncological surgeries were postponed, potentially affecting disease progression in some patients. Chemotherapy modifications: Some regimens were adjusted to reduce immunosuppression or treatment frequency. Telemedicine: Virtual consultations were expanded to minimise exposure. Treatment centres: Strict infection control protocols were implemented.
Recommendations for Cancer Patients
Vaccination: COVID-19 vaccines are safe and strongly recommended for cancer patients. Timing relative to treatment cycles should be discussed with the oncologist. Infection prevention: Hand hygiene, mask use in crowded settings and avoiding sick contacts remain relevant. Do not delay cancer treatment: Delaying surgery or chemotherapy due to COVID-19 fear can be more harmful than the infection risk itself. Telemedicine: Use virtual consultations when appropriate for routine follow-up.
Managing COVID-19 in Cancer Patients
Cancer patients who contract COVID-19 may require closer monitoring. Specific antiviral treatments (nirmatrelvir/ritonavir, remdesivir) may be indicated. Coordination between oncologist, infectious disease specialist and primary care is important. Hospitalization thresholds should be lower for immunocompromised patients.
Questions about managing cancer treatment during or after COVID-19? At Quenet Torrent Institute our team provides expert guidance for oncological patients. Request a consultation.